SearcharxivSearch

arXiv subjects

Peter A. Bath

Publications and source records attributed to Peter A. Bath.

2 recordsLinked to original sources

Evaluating the quality of published medical research with ChatGPT

Estimating the quality of published research is important for evaluations of departments, researchers, and job candidates. Citation-based indicators sometimes support these tasks, but do not work for new articles and have low or moderate accuracy. Previous research has shown that ChatGPT can estimate the quality of research articles, with its scores correlating positively with an expert scores proxy in all fields, and often more strongly than citation-based indicators, except for clinical medicine. ChatGPT scores may therefore replace citation-based indicators for some applications. This article investigates the clinical medicine anomaly with the largest dataset yet and a more detailed analysis. The results showed that ChatGPT 4o-mini scores for articles submitted to the UK's Research Excellence Framework (REF) 2021 Unit of Assessment (UoA) 1 Clinical Medicine correlated positively (r=0.134, n=9872) with departmental mean REF scores, against a theoretical maximum correlation of r=0.226. ChatGPT 4o and 3.5 turbo also gave positive correlations. At the departmental level, mean ChatGPT scores correlated more strongly with departmental mean REF scores (r=0.395, n=31). For the 100 journals with the most articles in UoA 1, their mean ChatGPT score correlated strongly with their REF score (r=0.495) but negatively with their citation rate (r=-0.148). Journal and departmental anomalies in these results point to ChatGPT being ineffective at assessing the quality of research in prestigious medical journals or research directly affecting human health, or both. Nevertheless, the results give evidence of ChatGPT's ability to assess research quality overall for Clinical Medicine, where it might replace citation-based indicators for new research.

cs.DL

Feasibility of sensor-based technology for monitoring health in developing countries - cost analysis and user perception aspects

Understanding the financial burden of chronic diseases in developing regions still remains an important economical factor which influences the successful implementation of sensor based applications for continuous monitoring of chronic conditions. Our research focused on a comparison of literature-based data with real costs of the management and treatment of chronic diseases in a developing country, and we are using Kosovo as an example here. The results reveal that the actual living costs exceed the minimum expenses that chronic diseases impose. Following the potential of a positive economic impact of sensor based platforms for monitoring chronic conditions, we further examined the users perception of digital technology. The purpose of this paper is to present the varying cost levels of treating chronic diseases, identify the users concerns and requirements towards digital technology and discuss issues and challenges that the application of sensor based platforms imply in low and middle income countries.

cs.CY